Dr Michal Wlodarski, Principal

Life Sciences

FOOD & AGRICULTURE

Next generation plant breeding;
Biological seed treatments;
Nanotechnology-based gene delivery;
Plant microbiome manipulation;
Drone imaging for field biomonitoring; etc.

FAST-MOVING CONSUMER GOODS

Sugar & carbohydrates substitutes;
Novel formulations;
Smart materials for packaging;
Non-thermal processing methods;
Traceability & shelf monitoring, etc.

MEDICAL DEVICES

E-health applications;
Wearables;
Robotic surgery;
Virtual reality for R&D and surgery
3D bioprinting, etc.

PHARMACEUTICALS

Machine learning for drug discovery;
Precision drug delivery and smart release;
Cell & gene therapeutics;
IoT for pharma manufacturing;
Immunotherapeutics; etc. 

Our industries of focus in Life Sciences.

LIFE SCIENCES

GLOBAL Cosmetics MNC

Technology landscaping and forecasting of photo-protector specialty chemicals and formulations for sunscreen applications.

 

READ MORE

LIFE SCIENCES

EU FOOD MNC

Market-pull and technology-push analysis of food technologies for dysphagia and anorexia followed by in-depth product innovation strategy.

READ MORE

LIFE SCIENCES

US BIOPHARMA SME

Advanced therapy area landscaping, forecasting and scouting for specific CNS applications and preclinical development support.

READ MORE

AIMDdetail.png

LIFE SCIENCES

EU MEDTECH SME

Identified approval pathways for the commercialisation and the competitive advantage of our client's medical device, and scouted for manufacturing partners.

 

READ MORE

Our most recent projects in Life Sciences.

Our most recent µInsight in Life Sciences.

Innovating Pharmaceutical Manufacturing

SUMMARY

The pharmaceutical industry is at a critical point, facing rapidly evolving social, healthcare, technological, and regulatory landscapes, as well as more informed and demanding patient groups. In response to these pressures, leaner drug development pipelines and manufacturing processes need to be developed and implemented, with the goal of increasing product quality, process agility, and operational cost-efficiency.
In the context of chemical manufacturing technologies, there has been little de novo innovation. Instead, most new process solutions either build on existing techniques (e.g. flow chemistry and capsule filling) or repurpose know-how from other disciplines (e.g. 3D printing and hot-melt extrusion). The next generation of pharmaceutical manufacturing systems, however, will be more tightly integrated with digital technologies and process analytical technologies (PATs).
PATs range from quality and risk management tools to process monitoring tools, and are particularly relevant for improving process efficiency, adaptability, robustness, and scalability. PATs accomplish these improvements through integration with innovative manufacturing techniques and technologies, including continuous manufacturing and the expanded use of lab robots. The overwhelming amounts of data generated by PATs will require new cloud-based and intelligent data management systems, such as the Internet-of-Things (IoT) infrastructure, to be properly managed. In addition, the cybersecurity of these systems will need to be ensured, and could rely on innovations such as blockchain technologies to track and validate data generated from production processes.
The synthesis of small molecule active pharmaceutical ingredients (APIs) is usually achieved through flow chemistry. PATs will also be important in these applications, as this method depends on microreactor systems. PATs can help maintain rigorous control of reaction conditions, which is essential when performing unstable reactions or using potentially hazardous compounds.
New techniques used in the final stage of manufacturing or moulding pharmaceutical products—including 3D printing, hot-melt extrusion, injection moulding, and capsule filling—all possess certain benefits and drawbacks, but have the potential to meet the growing need for more personalised, on-demand medicines.

 

READ FULL INSIGHT

visit

European Region

St John's Innovation Centre

Cowley Road

CB4 0WS Cambridge

United Kingdom

+44 (0)1223 926 926

North American Region

3532 Bee Caves Road

Suite 203

Austin TX 78746

United States of America

+1 (512) 988-2454

EMAIL

info [at] camin.com

follow

LinkedIn

Cambridge Innovation Consulting is an ISO certified organisation with 27001:2013 (# 317252019) and 9001:2015 (# 317242019) certifications.

COPYRIGHT 2020 - Cambridge Innovation Consulting